Emicizumab in the treatment of acquired hemophilia A: A Two-Center experience
Abstract Emicizumab is a FVIII mimetic antibody used in the treatment of inherited hemophilia A that could potentially be used in acquired hemophilia A (AHA) to achieve hemostasis and shorten hospital stay while reducing bypass therapies. We report on 12 cases of AHA patients treated with emicizumab...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer
2026-02-01
|
| Col·lecció: | Annals of Hematology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s00277-026-06905-5 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|